HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

5th Edition of Euro-Global Conference on Biotechnology and Bioengineering

September 18-20 | Hybrid Event

September 18-20, 2025 | London, UK

Stem Cell & Regenerative Medicine

Stem Cell & Regenerative Medicine

Regenerative strategies built around cell-based therapies are rapidly advancing through the field of stem cell & regenerative medicine. Harnessing the plasticity of embryonic, adult, and induced pluripotent stem cells, researchers are developing treatments for degenerative diseases, traumatic injuries, and organ failure. These cells serve as building blocks for regenerating damaged tissues and restoring physiological function. Breakthroughs in 3D scaffolding, organoid development, and bioprinting allow for realistic tissue reconstruction and disease modeling. Stem Cell & Regenerative Medicine is also at the forefront of clinical applications in orthopedics, cardiology, and neurology. With the integration of gene editing and immunomodulation, the therapeutic potential of stem cells is becoming more precise and patient-specific—moving regenerative therapies closer to routine clinical practice.

Committee Members
Speaker at Biotechnology and Bioengineering 2025 - Thomas J Webster

Thomas J Webster

Interstellar Therapeutics, United States
Speaker at Biotechnology and Bioengineering 2025 - Steve Busby

Steve Busby

University of Birmingham, United Kingdom
Speaker at Biotechnology and Bioengineering 2025 - Murray Moo Young

Murray Moo Young

University of Waterloo, Canada
ECBB 2025 Speakers
Speaker at Biotechnology and Bioengineering 2025 - Julia Sidorova

Julia Sidorova

Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Speaker at Biotechnology and Bioengineering 2025 - Luis Jesus Villarreal Gomez

Luis Jesus Villarreal Gomez

Universidad Autonoma de Baja California, Mexico
Speaker at Biotechnology and Bioengineering 2025 - Assad Al Ammar

Assad Al Ammar

Specialty Enzymes and Probiotics, United States
Speaker at Biotechnology and Bioengineering 2025 - Tina Moller Tagmose

Tina Moller Tagmose

Novo Nordisk A/S, Denmark
Tags

Submit your abstract Today

Watsapp
a